Lisa M Landrum

Summary

Affiliation: University of Oklahoma Health Sciences Center
Country: USA

Publications

  1. ncbi request reprint Gynecologic Oncology Group risk groups for vulvar carcinoma: improvement in survival in the modern era
    Lisa M Landrum
    Department of Obstetrics and Gynecology, Section of Gynecologic Oncology, Oklahoma University Health Sciences Center, PO Box 26901, WP2410, Oklahoma City, OK 73190, USA
    Gynecol Oncol 106:521-5. 2007
  2. ncbi request reprint Intraperitoneal chemotherapy for patients with advanced epithelial ovarian cancer: a review of complications and completion rates
    Lisa M Landrum
    Section of Gynecology Oncology, Department of Obstetrics and Gynecology, University of Oklahoma Health Sciences Center, P O Box 26901, WP 2410, Oklahoma City, OK 73190, USA
    Gynecol Oncol 108:342-7. 2008
  3. ncbi request reprint Comparison of outcome measures in patients with advanced squamous cell carcinoma of the vulva treated with surgery or primary chemoradiation
    Lisa M Landrum
    Department of Obstetrics and Gynecology, Section of Gynecologic Oncology, University of Oklahoma Health Sciences Center, PO Box 26901, Williams Pavilion 2410, Oklahoma City, OK 73190, USA
    Gynecol Oncol 108:584-90. 2008
  4. pmc A phase I trial of pegylated liposomal doxorubicin (PLD), carboplatin, bevacizumab and veliparib in recurrent, platinum-sensitive ovarian, primary peritoneal, and fallopian tube cancer: An NRG Oncology/Gynecologic Oncology Group study
    Lisa M Landrum
    Department of Ob Gyn, University of Oklahoma Health Sciences Center, Oklahoma City, OK, United States Electronic address
    Gynecol Oncol 140:204-9. 2016
  5. pmc Synthesis, X-ray structure, and characterization of a complex containing the hexakis(urea)cobalt(II) cation and lattice urea molecules
    Labrini Drakopoulou
    Department of Chemistry, University of Patras, 265 04 Patras, Greece
    Bioinorg Chem Appl . 2007
  6. pmc Exact interior reconstruction with cone-beam CT
    Yangbo Ye
    Department of Mathematics, University of Iowa, Iowa City, IA 52242, USA
    Int J Biomed Imaging 2007:10693. 2007
  7. pmc A context-sensitive active contour for 2D corpus callosum segmentation
    Qing He
    Department of Computer Science, College of Engineering, University of Missouri Columbia, Columbia, MO 65211, USA
    Int J Biomed Imaging 2007:24826. 2007
  8. pmc Molecular image segmentation based on improved fuzzy clustering
    Jinhua Yu
    Department of Electronic Engineering, Fudan University, Shanghai 200433, China
    Int J Biomed Imaging 2007:25182. 2007
  9. pmc Pneumococcal meningitis during pregnancy: a case report and review of literature
    Lisa M Landrum
    Section of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, Oklahoma University Health Sciences Center, Oklahoma City, OK 73190, USA
    Infect Dis Obstet Gynecol 2009:63624. 2009
  10. doi request reprint Phase II trial of vaginal cuff brachytherapy followed by chemotherapy in early stage endometrial cancer patients with high-intermediate risk factors
    Lisa M Landrum
    Section of Gynecology Oncology, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA Electronic address
    Gynecol Oncol 132:50-4. 2014

Collaborators

Detail Information

Publications20

  1. ncbi request reprint Gynecologic Oncology Group risk groups for vulvar carcinoma: improvement in survival in the modern era
    Lisa M Landrum
    Department of Obstetrics and Gynecology, Section of Gynecologic Oncology, Oklahoma University Health Sciences Center, PO Box 26901, WP2410, Oklahoma City, OK 73190, USA
    Gynecol Oncol 106:521-5. 2007
    ..The purpose of this study is to reassess these risk groups in patients treated in an era of contemporary management...
  2. ncbi request reprint Intraperitoneal chemotherapy for patients with advanced epithelial ovarian cancer: a review of complications and completion rates
    Lisa M Landrum
    Section of Gynecology Oncology, Department of Obstetrics and Gynecology, University of Oklahoma Health Sciences Center, P O Box 26901, WP 2410, Oklahoma City, OK 73190, USA
    Gynecol Oncol 108:342-7. 2008
    ..The purpose of this study was to review the completion rate of patients receiving i.p. chemotherapy as first line treatment at a single institution and determine what factors prohibit completion of therapy...
  3. ncbi request reprint Comparison of outcome measures in patients with advanced squamous cell carcinoma of the vulva treated with surgery or primary chemoradiation
    Lisa M Landrum
    Department of Obstetrics and Gynecology, Section of Gynecologic Oncology, University of Oklahoma Health Sciences Center, PO Box 26901, Williams Pavilion 2410, Oklahoma City, OK 73190, USA
    Gynecol Oncol 108:584-90. 2008
    ....
  4. pmc A phase I trial of pegylated liposomal doxorubicin (PLD), carboplatin, bevacizumab and veliparib in recurrent, platinum-sensitive ovarian, primary peritoneal, and fallopian tube cancer: An NRG Oncology/Gynecologic Oncology Group study
    Lisa M Landrum
    Department of Ob Gyn, University of Oklahoma Health Sciences Center, Oklahoma City, OK, United States Electronic address
    Gynecol Oncol 140:204-9. 2016
    ..To determine the tolerability at the MTD combined with bevacizumab...
  5. pmc Synthesis, X-ray structure, and characterization of a complex containing the hexakis(urea)cobalt(II) cation and lattice urea molecules
    Labrini Drakopoulou
    Department of Chemistry, University of Patras, 265 04 Patras, Greece
    Bioinorg Chem Appl . 2007
    ..Room temperature magnetic susceptibility and spectroscopic (solid-state UV/Vis, IR, Raman) data of 1 are discussed in terms of the nature of bonding and the known structure...
  6. pmc Exact interior reconstruction with cone-beam CT
    Yangbo Ye
    Department of Mathematics, University of Iowa, Iowa City, IA 52242, USA
    Int J Biomed Imaging 2007:10693. 2007
    ..These results have many implications in the CT field and can be extended to other tomographic modalities, such as SPECT/PET, MRI...
  7. pmc A context-sensitive active contour for 2D corpus callosum segmentation
    Qing He
    Department of Computer Science, College of Engineering, University of Missouri Columbia, Columbia, MO 65211, USA
    Int J Biomed Imaging 2007:24826. 2007
    ..Experimental results demonstrate the accuracy and robustness of our algorithm...
  8. pmc Molecular image segmentation based on improved fuzzy clustering
    Jinhua Yu
    Department of Electronic Engineering, Fudan University, Shanghai 200433, China
    Int J Biomed Imaging 2007:25182. 2007
    ..The 2DFCM can achieve 0.96 +/- 0.03 segmentation accuracy for synthetic images under different imaging conditions. Experimental results on a real molecular image also show the effectiveness of the proposed algorithm...
  9. pmc Pneumococcal meningitis during pregnancy: a case report and review of literature
    Lisa M Landrum
    Section of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, Oklahoma University Health Sciences Center, Oklahoma City, OK 73190, USA
    Infect Dis Obstet Gynecol 2009:63624. 2009
    ..Few cases of meningitis have been reported during pregnancy, many of which had devastating outcomes for mother, neonate, or both...
  10. doi request reprint Phase II trial of vaginal cuff brachytherapy followed by chemotherapy in early stage endometrial cancer patients with high-intermediate risk factors
    Lisa M Landrum
    Section of Gynecology Oncology, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA Electronic address
    Gynecol Oncol 132:50-4. 2014
    ....
  11. pmc Prognostic factors for stage III epithelial ovarian cancer treated with intraperitoneal chemotherapy: a Gynecologic Oncology Group study
    Lisa M Landrum
    University of Oklahoma Health Sciences Center, Section of GYN Oncology, Oklahoma City, OK 73104, USA
    Gynecol Oncol 130:12-8. 2013
    ..To determine prognostic factors for survival in ovarian cancer patients treated with intraperitoneal (IP) chemotherapy using ancillary data from cooperative group clinical trials...
  12. doi request reprint Stage IVB endometrial cancer: does applying an ovarian cancer treatment paradigm result in similar outcomes? A case-control analysis
    Lisa M Landrum
    Department of Obstetrics and Gynecology, Section of Gynecologic Oncology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA
    Gynecol Oncol 112:337-41. 2009
    ..The objective of this study is to evaluate overall survival (OS) and progression-free survival (PFS) in patients with advanced EC compared to a cohort of patients with OC matched for age and residual disease...
  13. doi request reprint Phase II trial of intraperitoneal cisplatin combined with intravenous paclitaxel in patients with ovarian, primary peritoneal and fallopian tube cancer
    Lisa M Landrum
    University of Oklahoma Health Sciences Center, Section of Gynecology Oncology, Oklahoma City, OK 73190, USA
    Gynecol Oncol 122:527-31. 2011
    ..CONCLUSIONS.: Although only 52% of patients were able to complete 6 cycles of cisplatin-based IP chemotherapy, significant reductions in cisplatin-related metabolic toxicity and catheter-related complications were noted...
  14. doi request reprint Ovarian cancer in the octogenarian: does the paradigm of aggressive cytoreductive surgery and chemotherapy still apply?
    Kathleen N Moore
    University of Oklahoma Health Sciences Center, Division of Gynecologic Oncology, Oklahoma City, Oklahoma 73103, USA
    Gynecol Oncol 110:133-9. 2008
    ..Optimal management for very elderly women (>80) is unclear. This study sought to review the experience with treating ovarian cancer in this population...
  15. doi request reprint Adjuvant chemotherapy for the "oldest old" ovarian cancer patients: can we anticipate toxicity-related treatment failure in a vulnerable population?
    Kathleen N Moore
    Division of Gynecologic Oncology, University of Oklahoma, Oklahoma City, Oklahoma 73104, USA
    Cancer 115:1472-80. 2009
    ..In the current study, chemotherapy-related toxicity data were evaluated between patients aged > or = 80 years and those aged < 80 years...
  16. pmc Tubal ligation frequency in Oklahoma women with cervical cancer
    Cara A Mathews
    Division of Gynecologic Oncology, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA
    Gynecol Oncol 127:278-82. 2012
    ..Infrequent Pap screening is an important risk factor for cervical cancer. We studied the association between contraceptive methods, screening frequency, and cancer...
  17. pmc Clinicopathologic Significance of Mismatch Repair Defects in Endometrial Cancer: An NRG Oncology/Gynecologic Oncology Group Study
    D Scott McMeekin
    D Scott McMeekin and Lisa M Landrum, University of Oklahoma Health Sciences Center, Oklahoma City, OK David L Tritchler, Heather A Lankes, and Shamshad Ali, NRG Oncology Statistics and Data Management Center Shashikant B Lele, Roswell Park Cancer Institute, Buffalo Michael L Pearl, Stony Brook University Hospital, Stony Brook, NY David E Cohn, Floor J Backes, and Paul J Goodfellow, The Ohio State University Nilsa Ramirez, Research Institute at Nationwide Children s Hospital, Columbus, OH David G Mutch, Matthew A Powell, and Feng Gao, Washington University School of Medicine, St Louis, MO Melissa A Geller, University of Minnesota, Minneapolis, MN Richard Zaino, Penn State Milton S Hersey Medical Center, Hershey, PA Russell D Broaddus, The University of Texas MD Anderson Cancer Center, Houston, TX Kathleen M Darcy, Women s Health Integrated Research Collective, Annandale, VA and Paul A DiSilvestro, Women and Infants Hospital of Rhode Island, Providence, RI
    J Clin Oncol 34:3062-8. 2016
    ..We undertook tumor typing to classify MMR defects to determine if MMR status is prognostic or predictive...
  18. pmc Pemetrexed and cisplatin for the treatment of advanced, persistent, or recurrent carcinoma of the cervix: a limited access phase II trial of the gynecologic oncology group
    David Scott Miller
    David Scott Miller, University of Texas Southwestern Medical Center, Dallas Lois M Ramondetta and Jubilee Brown, MD Anderson Cancer Center, Houston, TX John A Blessing, Roswell Park Cancer Institute, Buffalo, NY Huyen Q Pham, University of Southern California, Los Angeles Krishnansu S Tewari, University of California Medical Center at Irvine, Orange, CA and Lisa M Landrum and Robert S Mannel, University of Oklahoma, Oklahoma City, OK
    J Clin Oncol 32:2744-9. 2014
    ..Secondarily, this study will determine the effects of this regimen on progression-free survival and overall survival...
  19. ncbi request reprint Uterine leiomyoma with associated pseudo-Meigs syndrome mimicking ovarian carcinoma
    Lisa M Landrum
    Department of Obstetrics and Gynecology, 920 Stanton L Young Boulevard, Oklahoma City, OK 73104, USA
    J Okla State Med Assoc 101:38-9. 2008
    ..Uterine leiomyoma are commonly diagnosed in women of reproductive age. However, these benign tumors may present with clinical signs and symptoms that are consistent with ovarian carcinoma...